Lipid Nanoparticles Market Size, Share & Trends Analysis Report By Nanoparticle Type (Liposomes, Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, Others), By Molecule Type (siRNA, mRNA, Others), By Application (Therapeutics, Research), By End Use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs & CDMOs) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 20, 2026 | Author: Dhanashri B | Format: | Report Code: SR8137DR | Pages: 200

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Lipid Nanoparticles Market Size Analysis
    1. Introduction
    2. Lipid Nanoparticles Market Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
      1. Liposomes
      2. Solid Lipid Nanoparticles
      3. Nanostructured Lipid Carriers
      4. Others
    3. Lipid Nanoparticles Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. siRNA
      2. mRNA
      3. Others
    4. Lipid Nanoparticles Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Therapeutics
      2. Research
    5. Lipid Nanoparticles Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical & Biotechnology Companies
      2. Academic & Research Institutes
      3. CROs & CDMOs
  7. North America Lipid Nanoparticles Market Size Analysis
    1. Introduction
    2. Lipid Nanoparticles Market Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
      1. Liposomes
      2. Solid Lipid Nanoparticles
      3. Nanostructured Lipid Carriers
      4. Others
    3. Lipid Nanoparticles Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. siRNA
      2. mRNA
      3. Others
    4. Lipid Nanoparticles Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Therapeutics
      2. Research
    5. Lipid Nanoparticles Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical & Biotechnology Companies
      2. Academic & Research Institutes
      3. CROs & CDMOs
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
  8. Europe Lipid Nanoparticles Market Size Analysis
    1. Introduction
    2. Lipid Nanoparticles Market Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
      1. Liposomes
      2. Solid Lipid Nanoparticles
      3. Nanostructured Lipid Carriers
      4. Others
    3. Lipid Nanoparticles Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. siRNA
      2. mRNA
      3. Others
    4. Lipid Nanoparticles Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Therapeutics
      2. Research
    5. Lipid Nanoparticles Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical & Biotechnology Companies
      2. Academic & Research Institutes
      3. CROs & CDMOs
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    8. France
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
  9. APAC Lipid Nanoparticles Market Size Analysis
    1. Introduction
    2. Lipid Nanoparticles Market Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
      1. Liposomes
      2. Solid Lipid Nanoparticles
      3. Nanostructured Lipid Carriers
      4. Others
    3. Lipid Nanoparticles Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. siRNA
      2. mRNA
      3. Others
    4. Lipid Nanoparticles Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Therapeutics
      2. Research
    5. Lipid Nanoparticles Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical & Biotechnology Companies
      2. Academic & Research Institutes
      3. CROs & CDMOs
    6. China
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    9. India
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
  10. Middle East and Africa Lipid Nanoparticles Market Size Analysis
    1. Introduction
    2. Lipid Nanoparticles Market Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
      1. Liposomes
      2. Solid Lipid Nanoparticles
      3. Nanostructured Lipid Carriers
      4. Others
    3. Lipid Nanoparticles Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. siRNA
      2. mRNA
      3. Others
    4. Lipid Nanoparticles Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Therapeutics
      2. Research
    5. Lipid Nanoparticles Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical & Biotechnology Companies
      2. Academic & Research Institutes
      3. CROs & CDMOs
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
  11. LATAM Lipid Nanoparticles Market Size Analysis
    1. Introduction
    2. Lipid Nanoparticles Market Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
      1. Liposomes
      2. Solid Lipid Nanoparticles
      3. Nanostructured Lipid Carriers
      4. Others
    3. Lipid Nanoparticles Market Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
      1. siRNA
      2. mRNA
      3. Others
    4. Lipid Nanoparticles Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Therapeutics
      2. Research
    5. Lipid Nanoparticles Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical & Biotechnology Companies
      2. Academic & Research Institutes
      3. CROs & CDMOs
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      3. Market Size & Forecast By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
  12. Competitive Landscape
    1. Lipid Nanoparticles Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Merck KGaA (Germany)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Evonik Industries AG (Germany)
    3. Croda International Plc (UK)
    4. Precision NanoSystems Inc. (Canada)
    5. Acuitas Therapeutics Inc. (Canada)
    6. CordenPharma International (Germany)
    7. Exelead Inc. (US)
    8. NOF Corporation (Japan)
    9. FUJIFILM Corporation (Japan)
    10. Danaher (US)
    11. Thermo Fisher Scientific Inc. (US)
    12. Lonza Group AG (Switzerland)
    13. Catalent, Inc. (US)
    14. ST Pharm Co., Ltd. (South Korea)
    15. Genevant Sciences (Canada)
    16. Arcturus Therapeutics Holdings Inc. (US)
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: